Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» eosinophilic granulomatosis with polyangiitis
eosinophilic granulomatosis with polyangiitis
FDA Approves Fasenra for Treatment of Eosinophilic Granulomatosis with Polyangiitis
Managed Healthcare Executive
Wed, 09/18/24 - 11:03 pm
AstraZeneca
Fasenra
eosinophilic granulomatosis with polyangiitis
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
Clinical Trials Arena
Tue, 09/12/23 - 10:37 am
AstraZeneca
Fasenra
GSK
Nucala
eosinophilic granulomatosis with polyangiitis
clinical trials
Roche gets FDA nod for Rituxan to treat children with two blood vessel disorders
Pharmaceutical Business Review
Mon, 09/30/19 - 12:09 pm
Roche
FDA
Rituxan
eosinophilic granulomatosis with polyangiitis
microscopic polyangiitis
Astrazeneca's Fasenra Gets Orphan Drug Designation for Autoimmune Disease
Yahoo/Zacks.com
Tue, 11/27/18 - 12:09 pm
AstraZeneca
Fasenra
orphan drugs
FDA
eosinophilic granulomatosis with polyangiitis
GlaxoSmithKline, now vying with AstraZeneca, scores brand-new market for Nucala
Fierce Pharma
Wed, 12/13/17 - 11:07 am
GSK
AstraZeneca
Nucala
eosinophilic granulomatosis with polyangiitis